StockViz
Share URL
Embed chart view
-
Export .csv
-
Download image
-
Copy link
-
Embed code
StockViz
RANKINGS
Liaoning Cheng Da Co., Ltd.
Shanghai Stock Exchange:600739.SS
Sector
Location
Market Cap
USD 2.34 B
Share Price
USD 1.53
Avg Daily Volume
11,874,697
Change (1 day)
-0.09%
Change (1 year)
29.96%
Change (YTD)
7.90%
Liaoning Cheng Da Co., Ltd. Operating Income Margin for the year ending December 31, 2024: 6.66%
Liaoning Cheng Da Co., Ltd. Operating Income Margin is 6.66% for the year ending December 31, 2024, a 390.24% change year over year. Operating Income Ratio is the proportion of a company's operating income to its net sales, measuring the efficiency of its core business operations in generating profits.
-
Liaoning Cheng Da Co., Ltd. Operating Income Margin for the year ending December 31, 2023 was 1.36%, a -93.35% change year over year.
-
Liaoning Cheng Da Co., Ltd. Operating Income Margin for the year ending December 31, 2022 was 20.42%, a 42.25% change year over year.
-
Liaoning Cheng Da Co., Ltd. Operating Income Margin for the year ending December 31, 2021 was 14.35%, a -47.15% change year over year.
-
Liaoning Cheng Da Co., Ltd. Operating Income Margin for the year ending December 31, 2020 was 27.16%, a 112.95% change year over year.
Competitors
GE HealthCare Technologies Inc.
USD 75.95
GEHC
+1.88
2.54%
Laboratory Corporation of America Holdings
USD 264.26
LH
+1.75
0.67%
Torrent Pharmaceuticals Limited
USD 39.84
TORNTPHARM.NS
-0.07
-0.17%
Ascendis Pharma A/S
USD 172.00
ASND
-0.60
-0.35%
Regencell Bioscience Holdings Limited
USD 14.60
RGC
-2.44
-14.32%
Laurus Labs Limited
USD 8.78
LAURUSLABS.NS
+0.07
0.81%
ADMA Biologics, Inc.
USD 17.88
ADMA
-0.33
-1.81%
Ipca Laboratories Limited
USD 16.11
IPCALAB.NS
+0.08
0.51%
Hubei Jumpcan Pharmaceutical Co., Ltd.
USD 3.66
600566.SS
-0.01
-0.38%
Shijiazhuang Yiling Pharmaceutical Co., Ltd.
USD 1.97
002603.SZ
-0.01
-0.28%
Pfizer Limited
USD 66.48
PFIZER.NS
-0.07
-0.11%
BGI Genomics Co., Ltd.
USD 6.84
300676.SZ
-0.13
-1.84%
Eris Lifesciences Limited
USD 19.32
ERIS.NS
-0.26
-1.34%
Vimian Group AB (publ)
USD 4.21
VIMIAN.ST
+0.00
0.09%
Hybio Pharmaceutical Co., Ltd.
USD 2.41
300199.SZ
+0.01
0.29%
NovoCure Limited
USD 17.88
NVCR
+0.08
0.45%
Harmony Biosciences Holdings, Inc.
USD 32.03
HRMY
+0.43
1.36%
Adaptive Biotechnologies Corporation
USD 11.19
ADPT
-0.46
-3.95%
Tianjin Chase Sun Pharmaceutical Co.,Ltd
USD 0.55
300026.SZ
-0.00
-0.75%
Tibet Cheezheng Tibetan Medicine Co., Ltd.
USD 3.14
002287.SZ
-0.03
-0.79%
Key Data
| Date | Operating Income Margin | Gross Profit Margin | EBIT Margin | EBITDA Margin |
|---|
Competitors
GE HealthCare Technologies Inc.
USD 75.95
GEHC
+1.88
2.54%
Laboratory Corporation of America Holdings
USD 264.26
LH
+1.75
0.67%
Torrent Pharmaceuticals Limited
USD 39.84
TORNTPHARM.NS
-0.07
-0.17%
Ascendis Pharma A/S
USD 172.00
ASND
-0.60
-0.35%
Regencell Bioscience Holdings Limited
USD 14.60
RGC
-2.44
-14.32%
Laurus Labs Limited
USD 8.78
LAURUSLABS.NS
+0.07
0.81%
ADMA Biologics, Inc.
USD 17.88
ADMA
-0.33
-1.81%
Ipca Laboratories Limited
USD 16.11
IPCALAB.NS
+0.08
0.51%
Hubei Jumpcan Pharmaceutical Co., Ltd.
USD 3.66
600566.SS
-0.01
-0.38%
Shijiazhuang Yiling Pharmaceutical Co., Ltd.
USD 1.97
002603.SZ
-0.01
-0.28%
Pfizer Limited
USD 66.48
PFIZER.NS
-0.07
-0.11%
BGI Genomics Co., Ltd.
USD 6.84
300676.SZ
-0.13
-1.84%
Eris Lifesciences Limited
USD 19.32
ERIS.NS
-0.26
-1.34%
Vimian Group AB (publ)
USD 4.21
VIMIAN.ST
+0.00
0.09%
Hybio Pharmaceutical Co., Ltd.
USD 2.41
300199.SZ
+0.01
0.29%
NovoCure Limited
USD 17.88
NVCR
+0.08
0.45%
Harmony Biosciences Holdings, Inc.
USD 32.03
HRMY
+0.43
1.36%
Adaptive Biotechnologies Corporation
USD 11.19
ADPT
-0.46
-3.95%
Tianjin Chase Sun Pharmaceutical Co.,Ltd
USD 0.55
300026.SZ
-0.00
-0.75%
Tibet Cheezheng Tibetan Medicine Co., Ltd.
USD 3.14
002287.SZ
-0.03
-0.79%